Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy

Kidney International

Volumn 58, Issue 2, 2000, Pages 762-769

  Lacourcière, Yves ^{a,b,c,d,e,f,g}   Bélanger, André ^{a,b,c,d,e,f,g}   Godin, Chantal ^{a,b,c,d,e,f,g}   Hallé, Jean Pierre ^{a,b,c,d,e,f,g}   Ross, Stuart ^{a,b,c,d,e,f,g}   Wright, Noël ^{a,b,c,d,e,f,g}   Marion, Jean ^{a,b,c,d,e,f,g}  

^a LAVAL UNIVERSITY   (Canada)

^b Centre De Recherche   (Canada)

^c Centre de Recherche   (Canada)

^d MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

^g MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

Author keywords

Anti hypertensive therapy; Early nephropathy; Hypertension; NIDDM; Uric acid

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; ENALAPRIL; HEMOGLOBIN A1C; HYDROCHLOROTHIAZIDE; LOSARTAN; URIC ACID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIABETIC NEPHROPATHY; DOUBLE BLIND PROCEDURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL;

EID: 0033861035     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00224.x     Document Type: Article

References (34)

1. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes
2. Microalbuminuria: A major risk factor in type II diabetes: A 10-year follow-up study of 503 patients
3. Microalbuminuria predicts mortality in non-insulin-dependent diabetes
4. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
5. Differing effects of antihypertensive agents on urinary albumin excretion
6. Renal protection and antihypertensive drugs
7. Captopril or conventional therapy in hypertensive type II diabetics: Three year analysis
8. Effects of long-term enalapril treatment on persistent microalbuminuria in well-controlled hypertensive and normotensive NIDDM patients
9. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients
10. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension
11. Effects of the modulators of the reninangiotensin-aldosterone system on cough
12. Is the antiproteinuric effects of ACE Inhibition mediated by interference in the reninangiotensin system?
13. Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease
14. Losartan reduces albuminuria in patients with essential hypertension: An enalapril controlled 3 months study
15. Validation of portable noninvasive blood pressure monitoring devices: Comparison with intraarterial and sphygmomanometer measurements
16. Microalbuminuria, an early marker of renal involvement in diabetes
17. Selection of a routine method for determination of glomerular filtration rate in adult patients
18. Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension, one year analysis
19. Benefits of non-invasive blood pressure monitoring during hypertensive treatment
20. Ambulatory blood pressure monitoring and echocardiography left ventricular will thickness and mass
21. Relationship between albumin excretion rate, ambulatory blood pressure and left ventricular hypertrophy in mild hypertension
22. The prognostic value of ambulatory monitoring
23. Ambulatory blood pressure: An independent predictor of prognosis in essential hypertension
24. Diurnal variations of blood pressure and microalbuminuria in essential hypertension
25. Blood pressure by 24-hour ambulatory recording in type 2 (non-insulin-dependent) diabetes: Relationship to urinary albumin excretion
26. Ambulatory blood pressure and urinary albumin excretion in diabetic (non-insulin-dependent) hypertensive patients: Relationship at baseline and after treatment by the angiotensin converting enzyme inhibitor trandelapril
27. Antiproteinuric effect of blood pressure lowering agents: A meta-analysis of comparative trials
28. Hypertension and diabetes
29. Calcium channel blockers versus other antihypertensive therapies on progressions of NIDDM associated nephropathy
30. Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study
31. Serum uric acid and cardiovascular events in successfully treated hypertensive patients
32. Antihypertensive efficacy and tolerability of once daily losartan potassium compared with captopril in patients with mild to moderate essential hypertension
33. For the collaborative group: Efficacy and tolerability of losartan in hypertensive patients with renal impairment
34. Pilot study of the uricosuric effect of Dup 753, a new angiotensin II receptor antagonist, in healthy subjects